Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Sym-021 by Les Laboratoires Servier for Lymphoma: Likelihood of Approval
Sym-021 is under clinical development by Les Laboratoires Servier and currently in Phase I for Lymphoma. According to GlobalData, Phase...